No Prescription » Prescription Drugs 13 » Plaquenil Quineprox
Hydroxychloroquine is in a class of drugs called antimalarials. It is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments.Hydroxychloroquine comes as a tablet to take by mouth. For prevention of malaria in adults two tablets are usually taken once a week on exactly the same day of each week. The first dose is taken 1-2 weeks before traveling to an area where malaria is common and then doses are continued for 8 weeks after exposure. For treatment of acute attacks of malaria in adults four tablets are usually taken right away followed by two tablets 6-8 hours later and then two tablets on each of the next 2 days.For prevention or treatment of malaria in infants and children the amount of hydroxychloroquine is based on the child's weight. Your doctor will calculate this amount and tell you how much hydroxychloroquine your child should receive.For lupus erythematosus one or two tablets are usually taken once or twice daily. For rheumatoid arthritis one to three tablets are usually taken once a day.Hydroxychloroquine can be taken with a glass of milk or a meal to decrease stomach upset. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take hydroxychloroquine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.If you are taking hydroxychloroquine for symptoms of rheumatoid arthritis your symptoms should improve within 6 months. If your rheumatoid arthritis symptoms do not improve or if they worsen stop taking the drug and call your doctor. Once you and your doctor are sure the drug works for you do not stop taking hydroxychloroquine without talking to your doctor. Symptoms of rheumatoid arthritis will return if you stop taking hydroxychloroquine.Hydroxychloroquine is used occasionally to treat porphyria cutanea tarda.
Buy Plaquenil Quineprox and other Prescription Drugs 13 products online
at Medstore.
215 Buy Online at Medstore - Click Here!

About Plaquenil Quineprox:
Product Type: Prescription Drugs 13
Plaquenil ( Quineprox Generic Hydroxychloroquine )
Plaquenil (Quineprox Generic Hydroxychloroquine)
Quineprox Generic Hydroxychloroquine
200mg 100 tabs
Quineprox Generic Hydroxychloroquine Plaquenil

View more
Prescription Drugs 13
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|